Discontinuation report CARBAMAZEPINE CR
| Report ID | 108505 |
| Drug Identification Number | 02413604 |
| Brand name | CARBAMAZEPINE CR |
| Common or Proper name | CARBAMAZEPINE |
| Company Name | PRO DOC LIMITEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-03-11 |
| Remaining supply date | 2021-02-28 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Discontinued- Cessation de vente |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-03-11 | English | Compare |
| v2 | 2020-03-11 | French | Compare |
| v3 | 2020-03-12 | English | Compare |
Showing 1 to 3 of 3